权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The role of the SIRT1-LXR signaling axis in diabetes-induced cholesterol metabolism dysregulation

SIRT1-LXR信号轴在糖尿病引起的胆固醇代谢失调中的作用

基本信息

批准号：
9900014
负责人：
Sandra Suarez Hammer
金额：
$ 6.93万
依托单位：
MICHIGAN STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-04-01 至 2022-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9900014
关键词：
Address Adult Affect Age American Animal Model Biological Phenomena Blindness Cells Cholesterol Cholesterol Homeostasis Chronic Clinical Data Clinical Trials Complication Complications of Diabetes Mellitus Computer software Coupled Data Development Diabetes Mellitus Diabetic Retinopathy Disease Disease Progression Down-Regulation Dyslipidemias Epidemic Event Genes Goals Grant Heart failure Home environment Human Hyperglycemia Image Imaging Device Impairment Inflammatory Kidney Failure Knowledge LXRalpha protein Laboratories Life Lipids Liver X Receptor Mass Spectrum Analysis Measures Mentors Metabolic Pathway Metabolism Methodology Michigan Modeling Molecular Nature Pathology Pathway interactions Patients Pharmaceutical Preparations Pharmacology Pharmacotherapy Prevalence Proliferating Receptor Activation Receptor Signaling Research Research Personnel Research Proposals Resources Retina Risk Rodent Model Role SIRT1 gene Secondary to Severities Signal Pathway Signal Transduction Sterols Stroke Techniques Testing Therapeutic Training Triglycerides Type 2 diabetic Universities Up-Regulation Vision Work analytical tool arm career clinically significant design diabetic effective therapy glycemic control improved in vivo innovation lipid metabolism metabolomics novel novel therapeutics prevent retinal damage stem therapeutic target tool treatment optimization type I diabetic

项目摘要

Project Summary Diabetic retinopathy (DR) is a critical complication secondary to diabetes and is the number one cause of blindness in adults worldwide. Despite recent advances using pharmacotherapy, a cure for diabetic retinopathy has yet to be realized. Further understanding of the molecular events that cause disease progression will allow for the development of novel therapeutic solutions for this devastating disease. We believe that recent evidence from large clinical trials demonstrating a strong association between lipid abnormalities and DR progression as well as the discovery that pharmacological activation of liver X receptor (LXRα/LXRβ) prevents DR in rodent models, offers a potential breakthrough in our search for cure of DR. To achieve this goal, we propose to analyze retinal levels of SIRT1-LXR as well as investigate the impact DR has on the SIRT1-LXR signaling axis. This signaling axis promotes activation of cholesterol metabolism pathways as well as prevents upregulation of pro-inflammatory genes. Besides measuring retinal levels of SIRT1 and LXR, we also propose to measure retinal cholesterol metabolite leves in diabetic human cells as well as in an animal model of diabetes. This proposal allows for the unique opportunity to characterize human donor retinas into distinct stages of DR progression by using a novel imaging stitching software. This innovative imaging tool is readily used in the Busik Laboratory to determine if donor retinas are in the early, non-proliferative stage or are in the late, proliferative stage. Additionally, to ascertain if activation of this pathway is a potential therapy for DR in vivo, we propose to analyze the effect of SIRT1-LXR activation in a diabetic animal model. We hypothesize that activation of the SIRT1-LXR pathway will improve the deleterious effects seen on retinal cholesterol metabolism and alleviate the inflammatory state active in the diabetic milieu. Michigan State University is home to a world class Molecular Metabolism and Disease Core. Thus, we propose to take advantage of this resources to further characterize and analyze retinal cholesterol levels between control, early stages of DR as well as late proliferate DR stages. Additionally, we currently have the tools necessary to activate the SIRT1-LXR pathway in vivo, allowing us to determine if activation of the SIRT1-LXR pathway prevents DR formation.

项目总结